Código QR (código de barras bidimensional)

Carbapenem-resistant Enterobacterales (CRE) acquisition and molecular characterization following colistin monotherapy and colistin-meropenem combination therapy: findings from the AIDA randomized trial

Abstract Background Colistin-carbapenem combination therapy is frequently used for carbapenem-resistant Gram-negative infections, but its impact on subsequent acquisition of carbapenem-resistant Enterobacterales (CRE) requires further investigation. We evaluated the incidence of CRE acquisition and...

ver descrição completa

Na minha lista:
Principais autores: Amir Nutman, Elizabeth Temkin, Jonathan Lellouche, Maayan Amar Ben Dalak, Ella Kaplan, Mor Lurie-Weinberger, Yael Dishon Benattar, Ami Neuberger, Anat Stern, Vered Daitch, Noa Eliakim-Raz, Emanuele Durante-Mangoni, Mariano Bernardo, Domenico Iossa, George Daikos, Anna Skiada, Ioannis Pavleas, Lena Friberg, Ursula Theuretzbacher, Leonard Leibovici, Mical Paul, Yehuda Carmeli, AIDA Study Group
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2025-11-01
coleção:Antimicrobial Resistance and Infection Control
Assuntos:
Colistin
Meropenem
Combination treatment
Infection
Colonization
Carbapenem-resistant Enterobacterales (CRE)
Acesso em linha:https://doi.org/10.1186/s13756-025-01651-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados